Although polyphenols have shown anticarcinogenic activity in previous in vitro studies, the epidemiological study led by IDIBELL and the ICO has found no association between their concentration in blood and thyroid cancer.
A group of researchers from IDIBELL, CIBERSAM and the Hospital de Bellvitge have identified changes in the connection between the frontal cortex and subcortical regions in girls and boys with mild symptoms of obsessive-compulsive disorder (OCD).
Results could inform discussions on food packaging labels across Europe, say researchers. The study has the participation of Antonio Agudo and has been published in the journal The BMJ.
Until now, TP53 mutations had been associated with a syndrome with a high risk of developing cancer that did not include colorectal tumors.
TP53 proposed as a predisposing gene for colon cancer Read More »
This tool is able to identify single-person neurodegeneration before the symptom’s appearance, which could significate a more effective and personalized medicine.
A study has evaluated the efficacy and safety of the combination of 3 cycles of chemotherapy with immunotherapy before surgery, in 51 patients with locally advanced lung cancer, followed by one year of treatment with immunotherapy.
This study has used a new technique called ‘T-cell receptor (TCR) immuno-sequencing’, which allows us to obtain both the number of T lymphocytes that infiltrate the tumor and their clonality index.
Children with ‘SHMT2’ deficiency, the gene that causes the disease, have cognitive development problems, motor disorders and progressive heart disease that may even require transplantation.
Researchers discover a new genetic disease of the nervous and cardiac systems Read More »
Reducing the consumption of red and processed meat would not only reduce emissions but would also improve ‘planetary health’ since greenhouse gas (GHG) emissions are responsible for the so-called climate change.
The absence of ALKBH3 allows cancer cells to grow more freely and is an indicator of malignancy for this type of tumors. The study, published in Blood, has the participation of IDIBELL, ICO and HUB, among others.
ALKBH3 biomarker helps predict Hodgkin lymphoma aggressiveness Read More »
